Extension Agreement for Armada Health Care, BioRidge Pharma, and Hemispherx Biopharma Contracts

Contract Categories: Business Finance › Modification Agreements
Summary

Armada Health Care, BioRidge Pharma, and Hemispherx Biopharma have agreed to extend their existing contracts, originally signed in 2011 and previously extended, for an additional year through August 14, 2015. The extension maintains all current terms and conditions. The agreement is confirmed by the signature of Hemispherx Biopharma's CEO, Dr. William A. Carter.

Read More Arrow
EX-10.24 2 a1024-armadabioridge1.htm EXHIBIT 10.24 10.24 - Armada & BioRidge(1)

ARMADA
Health Care

August 8, 2014

Dr. William A. Carter Chairman and CEO Hemispherx Biopharma, Inc.
JFK Boulevard
Suite 500
Philadelphia, Pa 19103

Re: Agreements Between Armada Health Care, LLC and Hemispherx Biopharma, Inc. and
BioRidge Pharma and Hemispherx Biopharma, Inc.

Dear Dr. Carter,
Armada Health Care and BioRidge Pharma would like to request an extension to the above mentioned contracts initially signed on August 15, 2011 and extended in 2012 and 2013 through August 14, 2014 subject to the same terms and conditions currently in place.

Please sign this acceptance letter as acknowledgment of the extension through August 14, 2015 and return to my attention via fax or e-mail. I can be reached at ###-###-#### if you have any questions
or concerns.

Regards,

Ryan Oligino
Vice President
Armada Health Care
Phone: 973 ###-###-####
Fax: 973 ###-###-####


/S/: William A. Carter
 
(signature)
 
William A. Cartrer
 
(print name)
 
CEO and Chairman
 
(Title)
 
8/9/2014
 
(Date)